Form 4 for GANX Gain Therapeutics, Inc.
Accepted 2024-03-28 00:00:00 ET · period of report 2024-03-26 · accession 0001493152-24-011836 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-28 | 2024-03-26 | GANX | Alder Matthias | CEO, Dir | F - Tax | $4.06 | -6,085 | 21.1K | -22% | -$24.7K |
| DM | 2024-03-28 | 2024-03-26 | GANX | Alder Matthias | CEO, Dir | M - OptEx | — | +20.2K | 27.2K | +288% | — |
| DM | 2024-03-28 | 2024-03-26 | GANX | Alder Matthias | CEO, Dir | M - OptEx | $0.00 | -20.2K | 6,376 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-26 | F | D | 6,085 | $4.06 | 21,140 | D | — | — | (F2) Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. |
| 2 | Common | Common Stock | 2024-03-26 | M | A | 825 | — | 26,588 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. |
| 3 | Common | Common Stock | 2024-03-26 | M | A | 18,750 | — | 25,763 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. |
| 4 | Common | Common Stock | 2024-03-26 | M | A | 637 | — | 27,225 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. |
| 5 | Derivative | Restricted Stock Units | 2024-03-26 | M | D | 825 | $0.00 | 8,250 | D | — · — to — | 249 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. (F4) The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. |
| 6 | Derivative | Restricted Stock Units | 2024-03-26 | M | D | 18,750 | $0.00 | 56,250 | D | — · — to — | 18,750 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. (F3) The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. |
| 7 | Derivative | Restricted Stock Units | 2024-03-26 | M | D | 637 | $0.00 | 6,376 | D | — · — to — | 192 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. (F3) The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date. |